Nigerian propolis improves blood glucose, glycated hemoglobin A1c, very low-density lipoprotein, and highdensity lipoprotein levels in rat models of diabetes

Journal of Intercultural Ethnopharmacology

Volumn 5, Issue 3, 2016, Pages 233-238

  Oladayo, Mustafa Ibrahim ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Glycated hemoglobin; High density lipoprotein; Nigerian propolis; Plasma glucose; Very lowdensity lipoprotein

Indexed keywords

EID: 85014389666     PISSN: None     EISSN: 21468397     Source Type: Journal    
DOI: 10.5455/jice.20160502065029     Document Type: Article

References (40)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
2. Shi Y, Hu FB. The global implications of diabetes and cancer. Lancet 2014;383:1947-8
3. Pandey A, Tripathi P, Pandey R, Srivatava R, Goswami S. Alternative therapies useful in the management of diabetes: A systematic review. J Pharm Bioallied Sci 2011;3:504-12
4. Toreti VC, Sato HH, Pastore GM, Park YK. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med 2013;2013:697390
5. Sforcin JM, Bankova V. Propolis: Is there a potential for the development of new drugs? J Ethnopharmacol 2011;133:253-60
6. Huang S, Zhang CP, Wang K, Li GQ, Hu FL. Recent advances in the chemical composition of propolis. Molecules 2014;19:19610-32
7. Christov R, Trusheva B, Popova M, Bankova V, Bertrand M. Chemical composition of propolis from Canada, its antiradical activity and plant origin. Nat Prod Res 2006;20:531-6
8. Marquele FD, Di Mambro VM, Georgetti SR, Casagrande R, Valim YM, Fonseca MJ. Assessment of the antioxidant activities of Brazilian extracts of propolis alone and in topical pharmaceutical formulations. J Pharm Biomed Anal 2005;39:455-62
9. Teixeira EW, Message D, Negri G, Salatino A, Stringheta PC. Seasonal variation, chemical composition and antioxidant activity of Brazilian propolis samples. Evid Based Complement Alternat Med 2010;7:307-15
10. Bankova V, Popova M, Trusheva B. Propolis volatile compounds: Chemical diversity and biological activity: A review. Chem Cent J 2014;8:28
11. Fuliang HU, Hepburn HR, Xuan H, Chen M, Daya S, Radloff SE. Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus. Pharm Res 2005;51:147-52
12. Hassan SH. Effect of propolis on blood glycemic control and lipid metabolism in diabetic rabbits. Int J Pharm Life Sci 2014;5:4031
13. Kilpatrick ES, Bloomgarden ZT, Zimmet PZ. Is haemoglobin A1c a step forward for diagnosing diabetes? BMJ 2009;339:b4432
14. Miedema K. Standardization of HbA1c and optimal range of monitoring. Scand J Clin Lab Invest Suppl 2005;240:61-72
15. Lehman R, Krumholz HM. Tight control of blood glucose in long standing type 2 diabetes. BMJ 2009;338:b800
16. Shubrook JH Jr. Risks and benefits of attaining HbA(1c) goals: Examining the evidence. J Am Osteopath Assoc 2010;110:eS7-12
17. Etuk EU. Animal models for studying diabetes mellitus. Agric Biol J N Am 2010;1:130-4
18. Lenzen S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 2008;51:216-26
19. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001;50:537-46
20. Dunn JS, Sheehan HL, Mclethie NG. Necrosis of islets of langerhans produced experimentally. Lancet 1943;1:484-7
21. Danilova IG, Sarapultsev PA, Medvedeva SU, Gette IF, Bulavintceva TS, Sarapultsev AP. Morphological restructuring of myocardium during the early phase of experimental diabetes mellitus. Anat Rec (Hoboken) 2015;298:396-407
22. Musa TS, Salih NM, Ulaiwi WS. Detection of some active compounds in aqueous and ethanolic extracts of iraqi propolis and examine their antibacterial effects. Pak J Nutr 2012;11:83-7
23. Bhadauria M, Nirala SK, Shukla S. Propolis protects CYP 2E1 enzymatic activity and oxidative stress induced by carbon tetrachloride. Mol Cell Biochem 2007;302:215-24
24. Zamami Y, Takatori S, Koyama T, Goda M, Iwatani Y, Doi S, et al. Effect of propolis on insulin resistance in fructose-drinking rats. Yakugaku Zasshi 2007;127:2065-73
25. Viana MV, Moraes RB, Fabbrin AR, Santos MF, Gerchman F. Assessment and treatment of hyperglycemia in critically ill patients. Rev Bras Ter Intensiva 2014;26:71-6
26. Curie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL. Survival as a function of HbA1c in people with type 2 diabetes: A retrospective cohort study. Lancet 2010;375:481-9
27. Juarez DT, Demaris KM, Goo R, Mnatzaganian CL, Wong Smith H. Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience. Diabetes Metab Syndr Obes 2014;7:487-94
28. d’Emden MC, Shaw JE, Colman PG, Colagiuri S, Twigg SM, Jones GR, et al. The role of HbA1c in the diagnosis of diabetes mellitus in Australia. Med J Aust 2012;197:220-1
29. Incani M, Sentinelli F, Perra L, Pani MG, Porcu M, Lenzi A, et al. Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization. J Diabetes Investig 2015;6:44-50
30. Amin A, Mustafa IO, Folarin RO, Onanuga IO, Ibrahim RB, Balogun WG. Effect of Nigerian propolis on glycemia, lipid profile, and oxidative stress markers in alloxan-induced diabetic rats. Pharmacol Online 2013;2:149-58
31. Oršolic N, Sirovina D, Koncic MZ, Lackovic G, Gregorovic G. Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice. BMC Complement Altern Med 2012;12:117
32. Zhu W, Li YH, Chen ML, Hu FL. Protective effects of Chinese and Brazilian propolis treatment against hepatorenal lesion in diabetic rats. Hum Exp Toxicol 2011;30:1246-55
33. El-Sayedel SM, Abo-Salem OM, Aly HA, Mansour AM. Potential antidiabetic and hypolipidemic effects of propolis extract in streptozotocin-induced diabetic rats. Pak J Pharm Sci 2009;22:168-74
34. Iwu MM, Igboko OA, Okunji CO, Tempesta MS. Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola. J Pharm Pharmacol 1990;42:290-2
35. Douillet C, Bost M, Accominotti M, Borson-Chazot F, Ciavatti M. Effect of selenium and vitamin E supplements on tissue lipids, peroxides, and fatty acid distribution in experimental diabetes. Lipids 1998;33:393-9
36. Naziroglu M, Dilsiz N, Cay M. Protective role of intraperitoneally administered vitamins C and E and selenium on the levels of lipid peroxidation in the lens of rats made diabetic with streptozotocin. Biol Trace Elem Res 1999;70:223-32
37. Sosenko JM, Breslow JL, Miettinen OS, Gabbay KH. Hyperglycemia and plasma lipid levels: A prospective study of young insulindependent diabetic patients. N Engl J Med 1980;302:650-4
38. Brunzell JD, Chait A, Bierman EL. Plasma lipoproteins in human diabetes mellitus. The Diabetes Annual. Amsterdam: Elsevier; 1985. p. 463-79
39. Gonen B, White N, Schonfeld G, Skor D, Miller P, Santiago J. Plasma levels of apoprotein B in patients with diabetes mellitus: The effect of glycemic control. Metabolism 1985;34:675-9
40. Qiu S, Sun H, Zhang AH, Xu HY, Yan GL, Han Y, et al. Natural alkaloids: Basic aspects, biological roles, and future perspectives. Chin J Nat Med 2014;12:401-6.